Picture of Takara Bio logo

4974 — Takara Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Table: Takara Bio -Q1 group results

Jul 31 (Reuters)- 
             Takara Bio Inc. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2018        Jun 30, 2017     Mar 31, 2019 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             8.85                6.36             36.80    
                 (+39.2 pct)         (+0.8 pct)       (+13.9 pct) 
  Operating         1.54               262 mln            5.00    
                (+487.8 pct)         (-59.2 pct)      (+40.6 pct) 
  Recurring         1.56               287 mln            5.20    
                (+442.0 pct)         (-56.0 pct)      (+34.6 pct) 
  Net               1.03               22 mln             3.10    
                                     (-92.0 pct)      (+32.8 pct) 
  EPS             8.57 yen            0.19 yen         25.74 yen  
  Ann Div                             4.50 yen         6.00 yen   
  -Q2 div                                NIL              NIL     
  -Q4 div                             4.50 yen         6.00 yen   
  
  NOTE - Takara Bio Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T

Recent news on Takara Bio

See all news